Trulieve CEO Kim Rivers to Give Keynote Address at Benzinga Cannabis Capital Conference
- 49
PR Newswire
TALLAHASSEE, Fla., Feb. 23, 2021
Trulieve Cannabis Corp. CEO Kim Rivers will be speaking at 3:05 p.m. EST, February 25th at Benzinga's Virtual Cannabis Capital Conference Guzman
TALLAHASSEE, Fla., Feb. 23, 2021 /PRNewswire/ - Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a United States-based leading medical cannabis company, announced today that CEO Kim Rivers will be speaking at the Benzinga Cannabis Capital Conference, Thursday, February 25, 2020, at 3:05 p.m. EST. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis space.
For more information regarding registering for the Benzinga conference please visit: https://events.benzinga.com/ccc-free-registration
About Trulieve
Trulieve is primarily a vertically integrated "seed-to-sale" company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com.
View original content:http://www.prnewswire.com/news-releases/trulieve-ceo-kim-rivers-to-give-keynote-address-at-benzinga-cannabis-capital-conference-301233734.html
SOURCE Trulieve Cannabis Corp.
- EQS-News: Rekrutierung abgeschlossen: Berlin Cures erreicht wichtigen Meilenstein in der Phase-II-Studie mit BC 007 zur Behandlung von Long COVID
- MABEWO Gruppe: Indoor Farming für die Produktion von hochwertigem Cannabis
- EQS-News: OHB SE: Konzernabschluss 2023
- EQS-News: Mayr-Melnhof Karton AG: MM veröffentlicht Ergebnisse zum 1. Quartal 2024
- EQS-News: ekrutierung abgeschlossen: Berlin Cures erreicht wichtigen Meilenstein in der Phase-II-Studie mit BC 007 zur Behandlung von Long COVID
- Wechsel im Management von Valora Food Service: Sebastian Kayser und Sebastian Gooding übernehmen von Thomas Eisele